MeSH D012373 - rocky mountain spotted fever
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D000073605:Spotted fever group rickettsiosis
0 Companies
0 Drugs
Success rate
D012373:Â
Rocky mountain spotted fever
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Doxycycline hyclate | Doxy-lemmon |  | 1984-06-15 |  |  |
| Mylan | Doxycycline hyclate | Doxycycline |  | 2012-08-21 |  |  |
| Doxycycline hyclate | Doxycycline Hyclate |  | 1983-02-15 |  |  | |
| Mayne Group | Doxycycline hyclate | Doryx |  | 1985-07-22 |  |  |
| Doxycycline hyclate | Doryx Mpc | 2022-12-15 | 2005-05-06 |  |  | |
| Chartwell Pharmaceuticals | Doxycycline hyclate | Acticlate |  | 2014-07-25 |  |  |
| Doxycycline hyclate | Acticlate Cap |  | 2016-04-26 |  |  | |
| Doxycycline | Doxycycline |  | 2008-07-16 |  |  | |
| Doxycycline hyclate | Doxycycline Hyclate |  | 1984-09-11 |  |  | |
| Doxycycline hyclate | Lymepak |  | 2018-06-15 |  |  | |
| Doxycycline | Monodox |  | 1989-12-29 |  |  | |
| Lupin Research | Doxycycline | Doxycycline |  | 2013-03-18 |  |  |
| Doxycycline hyclate | Doxycycline Hyclate |  | 2023-08-11 |  |  | |
| Sandoz | Doxycycline | Doxycycline |  | 2000-06-30 |  |  |
| Bausch Health Companies | Doxycycline hyclate | Doxycycline Hyclate |  | 2005-12-21 |  |  |
| Pfizer | Doxycycline hyclate | Vibra-tabs |  | 1982-01-01 |  |  |
| Doxycycline, Doxycycline hyclate | Vibramycin |  | 1982-01-01 |  |  | |
| Cosette Pharmaceuticals | Doxycycline | Doxycycline |  | 2015-05-28 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
100%4/4
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use